Judith Hasko > WilmerHale > San Francisco, United States > Lawyer Profile
WilmerHale Offices

1 Front Street
Suite 3500
CALIFORNIA
94111
United States
- Firm Profile
- Go to...
Judith Hasko

Work Department
Emerging Company and Venture Capital; Life Sciences; Healthcare; Technology Transactions and Licensing
Position
Partner
Co-Chair, Life Sciences Group
Career
Judith Hasko serves as co-chair of WilmerHale’s Life Sciences Practice. She provides counsel to life sciences companies and their investors on strategic, intellectual property and technology-based commercial transactions. Companies in the biotechnology, pharmaceutical, medical device and diagnostic product sectors, along with their investors, depend on Ms. Hasko for guidance and execution of licensing, corporate partnerships, joint ventures, co-promotion arrangements, manufacturing and distribution agreements, asset purchases and royalty stream transactions.
Widely recognized for her market-leading transactional work, Ms. Hasko brings complementary business and scientific perspectives to her legal representations. Her work in the life sciences industry is consistently recognized by Chambers USA, The Legal 500 United States, IAM Patent and LMG Life Sciences. Ms. Hasko is a Certified Licensing Professional (CLP), and a member of the Patent Bar. Prior to attending law school, she was part of Genentech’s cardiovascular research department.
Prior to joining the firm, Ms. Hasko was a partner in the Silicon Valley office of another major international law firm, where served as vice chair of their Healthcare & Life Sciences Practice.
Professional Activities
Ms. Hasko has co-authored several scientific publications and frequently lectures on life sciences commercial topics in both industry and academic settings, including at Berkeley Law and Stanford University.
Memberships
Bar Admissions:
California
US Patent and Trademark Office
Education
JD, University of Wisconsin Law School, 1994
MPhil, University of Sussex, 1988
BA, Vassar College, 1986
Lawyer Rankings
United States > Intellectual property > Patents: licensing
(Leading partners)United States > Healthcare > Life sciences
(Leading partners)WilmerHale’s client base encompasses biotech, pharma, diagnostic, and medical device companies, along with investors and academic institutions. The firm supports client growth by counseling on corporate and commercial transactions, with strong work in strategic collaborations and license agreements, as well as financing and M&A. With longstanding expertise in IP, the firm also serves as lead counsel on patent litigation cases. The practice is co-headed by Judith Hasko, who joined the Palo Alto office from Latham & Watkins LLP and advises on commercial transactions such as strategic alliances, joint ventures, and manufacturing and distribution agreements, and Boston-based Stuart Falber, who specializes in financing, M&A, and collaborations and licensing transactions. Jekkie Kim, also joining the Palo Alto team from Latham & Watkins LLP, focuses on joint ventures, strategic licensing and collaborations, and other complex commercial transactions.
Lawyer Rankings
- Leading partners United States > Intellectual property > Patents: licensing
- Leading partners United States > Healthcare > Life sciences
- Life sciences United States > Healthcare
Top Tier Firm Rankings
- Dispute resolution > Appellate: courts of appeals / Appellate: supreme courts (states and federal)
- Antitrust > Cartel
- Antitrust > Civil litigation/class actions: defense
- Industry focus > Education
- Environment > Environment: regulatory
- Intellectual property > Patents: licensing
- Industry focus > Native American law
- Intellectual property > Patents: litigation (full coverage)
- Dispute resolution > Securities litigation: defense
Firm Rankings
- Finance > Financial services regulation
- International trade and national security > CFIUS
- Media, technology and telecoms > Cyber law (including data privacy and data protection)
- Dispute resolution > General commercial disputes
- M&A/corporate and commercial > M&A: middle-market ($500m-999m)
- Media, technology and telecoms > Outsourcing
- Government > State attorneys general
- International trade and national security > Trade remedies and trade policy
- M&A/corporate and commercial > Venture capital and emerging companies
- Finance > Capital markets: debt offerings
- Finance > Capital markets: equity offerings
- International trade and national security > Customs, export controls and economic sanctions
- Government > Government contracts
- Government > Government relations
- Healthcare > Life sciences
- Intellectual property > Patents: litigation (International Trade Commission)
- Media, technology and telecoms > Technology transactions
- M&A/corporate and commercial > Corporate governance
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Environment > Environment: regulatory
- Dispute resolution > Financial services litigation
- Finance > Fintech
- Dispute resolution > International arbitration
- Media, technology and telecoms > Media and entertainment: litigation
- Antitrust > Merger control
- Tax > US taxes: non-contentious
- Finance > Commercial lending
- Finance > Restructuring (including bankruptcy): corporate
- Dispute resolution > Corporate investigations and white-collar criminal defense